Elicera Therapeutics AB Sustainability Reports
Elicera Therapeutics AB is a clinical-stage cell and gene therapy company developing next-generation immuno-oncology treatments. The company's pipeline includes CAR T-cell therapies and oncolytic viruses designed to target solid tumors.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300I35L0R4INBFG27
FIGI: BBG01161YY69
11 reports from 2015 to 2025
